• Huntington disease
  • Smith-Magenis Syndrome, Potocki-Lupski Syndrome (17p11.2 Duplication/Deletion)
  • Heparin-PF4 Antibody (HIT)
  • Nortriptyline, Urine
  • Mucolipidosis Type IV (MCOLN1) Mutation Analysis
  • C1 Esterase Inhibitor, Antigen
  • Hypopituitarism
  • Folic Acid (Folate), RBC
  • Chromosome Analysis, Skin Biopsy
  • Cerebrospinal Fluid Microscopic Evaluation, Cell Count and Differentiation
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cytochrome P450 21A2 (CYP21A2) Genotyping
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cytochrome P450 21A2 (CYP21A2) Genotyping
Medical Test

Turnaround Time
Access to Cytochrome P450 21A2 (CYP21A2) Genotyping is restricted.